Long-term drug resistance was assessed by seeding in parallel 2.5 × 10
5 and 5 × 10
5 cells in 6-cm plates and 24 h after plating cells were treated with 1 μM of a particular inhibitor as single or double treatment. For the plates where the initial cell number was 2.5 × 10
5, medium and inhibitor(s) were changed every 3 days for 14 days. Cells were fixed and stained with Crystal Violet solution, pictures were captured with EPSON
PERFECTION V300 PHOTO scanner and images acquired with the paired software. taken. For the plates whose initial cell number was 5 × 10
5, medium and inhibitor(s) were changed every 3 days until plates were fully confluent. At confluence plates were split 1:5 to one 6-cm-plate without inhibitor(s) (1/5), in order to test for possible drug addiction, a 10-cm-plate with inhibitor(s) (3/5) for expansion/freezing and one 6-cm-plate with inhibitor(s) (1/5) for future protein isolation. Days after resistance were counted from the splitting time until the plates reached confluence again. Inhibitors used were
RO5126766 (CH5126766) (Selleckchem, Houston, TX, USA, S7170),
GDC-0623 (Selleckchem, Houston, TX, USA, S7553),
SCH772984 (Selleckchem, Houston, TX, USA, S7101),
LY3214996 (Selleckchem, Houston, TX, USA, S8534). Final DMSO concentration was kept at 0.1% in control and inhibitor-treated cells for single treatments and 0.2% for double treatments.
Catalano A., Adlesic M., Kaltenbacher T., Klar R.F., Albers J., Seidel P., Brandt L.P., Hejhal T., Busenhart P., Röhner N., Zodel K., Fritsch K., Wild P.J., Duyster J., Fritsch R., Brummer T, & Frew I.J. (2021). Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition. Cancers, 13(8), 1852.